Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2002British Journal of HaematologyOpen Access

Anti‐CD20 monoclonal antibody (Rituximab) for life‐threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSilverio PerrottaUniversity of Campania "Luigi Vanvitelli"FLFranco LocatelliUniversità Cattolica del Sacro CuoreAMAngela La MannaUniversity of Padua

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Perrotta et al. (2002) studied this question.

synapsesocial.com/papers/6a1d498633e2df9c962f4387https://doi.org/10.1046/j.1365-2141.2002.03278.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rituximab for myasthenia gravis developing after bone marrow transplant2000 · 142 citations
  2. 2Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab2000 · 125 citations
  3. 3Damage in systemic lupus erythematosus and its association with corticosteroids2000 · 495 citations
  4. 4Rituxan in the Treatment of Cold Agglutinin Disease1998 · 98 citations
  5. 5Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD201994 · 1,948 citations